Synergy of Urokinase-Type Plasminogen Activator Receptor Isomer (D1D2) and Integrin Α5β1 Causes Malignant Transformation of Hepatic Cells and the Occurrence of Liver Cancer

Molecular Medicine Reports - Greece
doi 10.3892/mmr.2014.2503
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Urokinase-Type Plasminogen Activator Supports Liver Repair Independent of Its Cellular Receptor

BMC Gastroenterology
MedicineGastroenterology
2006English

Requirement of Receptor-Bound Urokinase-Type Plasminogen Activator for Integrin Αvβ5-Directed Cell Migration

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1996English

Accessibility of Receptor-Bound Urokinase to Type-1 Plasminogen Activator Inhibitor.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1989English

Urokinase Type Plasminogen Activator Receptor Expression in Colorectal Neoplasms

Gut
Gastroenterology
1998English

Ligand Binding Regions in the Receptor for Urokinase-Type Plasminogen Activator

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2001English

Plasminogen Activator Urokinase Receptor (PLAUR; uPAR; suPAR)

Science-Business eXchange
2013English

Circulating Soluble Urokinase-Type Plasminogen Activator Receptor in Obstructive Sleep Apnoea

Medicina
Medicine
2020English

Detection of the Receptor for the Human Urokinase-Type Plasminogen Activator Using Fluoresceinated uPA

Journal of Histochemistry and Cytochemistry
AnatomyHistology
1997English

Soluble Urokinase-Type Plasminogen Activator Receptor in Black Americans With CKD

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy